4/22/2014 9:14:35 AM
IRVINE, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that the reverse stock split approved by the Company's stockholders at last week's annual stockholder's meeting became effective as of the opening of trading on Tuesday, April 22, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by